Cargando…
A review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights
Significant improvements in the management of hepatocellular carcinoma (HCC) during the past three years have urged the timely update of clinical guidelines in China. In brief, aMAP score is newly recommended as an effective risk stratification tool to predict HCC occurrence especially for non-cirrh...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10129899/ https://www.ncbi.nlm.nih.gov/pubmed/37124695 http://dx.doi.org/10.21037/hbsn-22-469 |